Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Follicular Lymphoma, Clinical Management

Pier Luigi Zinzani

MD, PhD

🏢University of Bologna🌐Italy

Full Professor of Hematology; Director, Institute of Hematology L. e A. Seragnoli

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Pier Luigi Zinzani is one of Europe's foremost lymphoma experts and a prolific clinical investigator in follicular lymphoma. He has led and participated in pivotal trials of obinutuzumab, rituximab-based regimens, and novel PI3K inhibitors in follicular lymphoma. His research spans frontline and relapsed/refractory FL, with contributions to understanding optimal maintenance strategies and management of transformation. He is a founding member of multiple Italian and European lymphoma cooperative groups and serves in leadership roles at ESMO and ICML.

Share:

🧪Research Fields 研究领域

follicular lymphoma management
lymphoma Italian practice
obinutuzumab FL
rituximab maintenance
PI3K inhibitors lymphoma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Pier Luigi Zinzani 的研究动态

Follow Pier Luigi Zinzani's research updates

留下邮箱,当我们发布与 Pier Luigi Zinzani(University of Bologna)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment